Skip navigation

Calls to Action

arbaclofen

Autism Speaks Names New Head of Medical Research

Pediatrician-scientist Paul Wang will oversee organization’s portfolio of medical research with emphasis on clinical studies
September 30, 2013

Behavioral-developmental pediatrician Paul Wang has joined Autism Speaks as its new senior vice president and head of medical research. He will oversee the organization’s medical research portfolio, with a strong focus on clinical studies.  

Autism Speaks Names Paul Wang, M.D., Senior Vice President and Head of Medical Research

Physician-scientist will be responsible for innovating Autism Speaks’ medical research portfolio, focus on clinical trial capabilies

September 30, 2013

New York, N.Y. (September 30, 2013) – Autism Speaks, the world’s leading autism science and advocacy organization, has named physician-scientist Paul Wang to the position of senior vice president and head of medical research. He will be responsible for innovating Autism Speaks’ medical research portfolio with a specific focus innovating clinical trial capabilities.  

Early Results from Autism Study: Arbaclofen May Improve Sociability

If benefits and safety confirmed by additional trials, medicine could become first to treat a core symptom of autism
May 01, 2013

 

Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments

DELSIA’s First Award funded by Autism Speaks Supports Development of Arbaclofen and other Innovative Treatments for ASD

Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership be

December 03, 2012

New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to discover biomarkers that can be used to facilitate the development of safe, effective and personalized treatments of autism spectrum disorders (ASD).